Navigation Links
PAREXEL International To Present At Raymond James Investors Conference And Barclays Capital Healthcare Conference

BOSTON, Feb. 28, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Raymond James Investors Conference in Orlando, FL.  James Winschel, Sr. Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 9:50 a.m.  ET on Tuesday, March 5, 2013.

PAREXEL will also be presenting at the Barclays Capital Healthcare Conference in Miami, FL.  James Winschel, Sr. Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 2:00 p.m.  ET on Tuesday, March 12, 2013.

A live webcast of the presentations will be available through the "Investors" section of PAREXEL's website at in the Upcoming Events portion of the main page, and a replay of the presentation will be available on the website until June 5, 2013.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 74 locations throughout 51 countries around the world, and has approximately 14,000 employees, including 282 employees related to the acquisition of Liquent. For more information about PAREXEL International visit

PAREXEL is a registered trademark of PAREXEL International Corporation, Perceptive Informatics is a trademark of Perceptive Informatics, Inc., and Liquent is a registered trademark of Liquent, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc., Liquent, Inc. or their respective owners and are hereby acknowledged.


Jill Baker , Corporate Vice President, Investor Relations

PAREXEL International

Tel: +781-434-4118



SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PAREXEL International To Present At Citi Global Healthcare Conference
2. PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
3. PAREXEL International To Present At Oppenheimer Healthcare Conference
4. PAREXEL International To Present At Lazard Capital Healthcare Conference And Jefferies Global Healthcare Conference
5. PAREXEL and Salem State University Launch Clinical Trial Management Graduate Program
6. PAREXEL International to Present at Robert Baird Healthcare Conference
7. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
8. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
9. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
10. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2012 Earnings Release and Conference Call
11. PAREXEL International To Present At NASDAQ OMX Investor Conference
Post Your Comments:
(Date:11/30/2015)... Months Ended 30 September 2015 2014RestatedChange%Turnover 545,575 , 518,852 , ... 384,242 , 9.8 Hospital Management Service Income ... (18.3) Medical Insurance Administration Service Income , 2,780 ... and Accessories Sales , 89,645 , 94,580 ... 2,822 , 2,917 , (3.3) Gross ...
(Date:11/30/2015)... , Nov. 30, 2015  PTS Diagnostics, the U.S.-based ... ® analyzers, A1CNow ® systems, and PTS ... family of patents that will propel the company into ... and Europe . The technology is ... as those on smartphones and tablets, and uses test ...
(Date:11/30/2015)... -- Cumberland Pharmaceuticals (CPIX), today announced that A.J. Kazimi , ... 3, 2015. TIME: 3:15p.m. ET LINK: ... --> DATE: Thursday, December 3, ... --> --> This will be ... ask the company questions in real-time - both in the ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... While powdered supplements and drinks can reduce food ... inventor from Chesterfield, Va., has found an easy to keep track of the scoop. ... measure powdered contents in a canister or other container handy and readily accessible. As ...
(Date:11/30/2015)... ... November 30, 2015 , ... Volpara ... breast density assessment and enterprise analytics solutions, here at the 101st Annual ... Hall booth #2377). Volpara’s quantitative breast imaging tools enable personalized measurements of ...
(Date:11/30/2015)... DC (PRWEB) , ... November ... ... Inc. (AIS) is pleased to announce the speakers for “Value-Based Payer-Provider Partnerships: ... lessons learned from three innovative value-based care arrangements: Essentia Health and UCare, ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... alliance around Novus’ TIGR® Matrix Surgical Mesh technology for soft tissue repair in ... TIGR® Matrix is a long-term resorbable surgical mesh intended to support and reinforce ...
(Date:11/30/2015)... ... November 30, 2015 , ... GKhair & Tibolli team members and artists ... Show held on November 8th and 9th at the Puerto Rico Convention Center, San ... renowned beauticians and top of the line fashion journalists. The San Juan Beauty Show ...
Breaking Medicine News(10 mins):